Weekly Dose: teriparatide, the osteoporisis drug that forms new bone

Weekly Dose: teriparatide, the osteoporosis drug that forms new bonePeter Robert Ebeling, Monash UniversityTeriparatide is an injectable drug to treat severe osteoporosis, a condition where mineral loss causes the bones to become brittle and to fracture easily.Teriparatide improves bone strength by stimulating the formation of new bone. It does this by increasing activity of bone-forming

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Bexsero vaccine shortage in Australia
Next GP-pharmacist model at Camp Hill 'impressive,' says Ley